Characterization of neuronal dystrophy induced by fibrillar amyloid β: implications for Alzheimer’s disease-Reference-Cited by-同舟云学术

Characterization of neuronal dystrophy induced by fibrillar amyloid β: implications for Alzheimer’s disease

Published:2002-09 Issue:1 Volume:114 Page:265-273
ISSN:0306-4522
Container-title:Neuroscience
language:en
Short-container-title:Neuroscience

Author:

Grace E.A,Rabiner C.A,Busciglio J

Publisher

Elsevier BV

Subject

General Neuroscience

Reference51 articles.

1. Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins;Aplin;Pharmacol. Rev.,1998

2. Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5;Baumann;FEBS Lett.,1993

3. Alzheimer’s disease-like dystrophic neurites characteristically associated with senile plaques are not found within other neurodegenerative diseases unless amyloid beta-protein deposition is present;Benzing;Brain Res.,1993

4. Rapid impact of beta-amyloid on paxillin in a neural cell line;Berg;J. Neurosci. Res.,1997

5. Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells;Busciglio;Proc. Natl. Acad. Sci. USA,1993

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population Pharmacokinetic Modeling and Simulation for Dose Optimization of GB-5001, a Long-Acting Intramuscular Injection of Donepezil, in Healthy Participants;Neurology and Therapy;2024-08-10

2. Physiological Mechanisms Inherent to Diabetes Involved in the Development of Dementia: Alzheimer’s Disease;Neurology International;2023-10-10

3. The pathomimetic oAβ25–35 model of Alzheimer's disease: Potential for screening of new therapeutic agents;Pharmacology & Therapeutics;2023-05

4. Application of the Loewner Equation for Neurite Outgrowth Mechanism;Chaos Theory - Recent Advances, New Perspectives and Applications [Working Title];2022-11-06

5. The molecular mechanism, targets, and novel molecules in the treatment of Alzheimer’s disease;Bioorganic Chemistry;2022-02